ERBB2 and breast carcinoma: IgG autoantibodies to HER2, p53, CEA, and CYCLIN B1 differentiated women subsequently diagnosed with breast cancer from controls with AUC 0.79 (CI 0.72–0.85, p < 0.0001)3.